Prokinetic agents in postgastrectomy patients.
Postgastrectomy syndromes are uncommon but, unfortunately, frustrating for both patient and physician, because treatment with prokinetic agents is often of limited benefit. This article examines the evidence for efficacy of available prokinetic drugs in the management of these difficult disorders.
Patterson
D J
DJ
Section of Gastroenterology, Virginia Mason Medical Center, Seattle, Washington.
D018723:Bethanechol; D001626:Bethanechol Compounds / Q000627:therapeutic use; D020117:Cisapride; D004294:Domperidone / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D005746:Gastric Emptying / Q000187:drug effects*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011178:Postgastrectomy Syndromes / Q000188:drug therapy*
D001626:Bethanechol Compounds; D010880:Piperidines; D018723:Bethanechol; D004294:Domperidone; D004917:Erythromycin; D008787:Metoclopramide; D020117:Cisapride